Skip to main content
. 2023 Jun 29;11:1187934. doi: 10.3389/fpubh.2023.1187934

Table 3.

Proportion of multi-drug resistant isolates along with the ESBL+ rate between genders and age groups.

Frequency MDR isolates (%) EBSL+ rate (%)
Gender Males (n = 39) 66 43
Females (n = 20) 34 22
Age group 0–12 years (n = 36) 61 41
20–49 years (n = 8) 14 7
50+ years (n = 15) 25 17